ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Systemic therapy regimens used for high-grade gliomas

Systemic therapy regimens used for high-grade gliomas
Bevacizumab  10 mg/kg days 1, 15  Every 4 weeks 
15 mg/kg days 1, 22  Every 6 weeks 
Carmustine (BCNU) 150 to 200 mg/m2 day 1 Every 6 weeks
Lomustine (CCNU) 90 to 110 mg/m2 day 1  Every 6 weeks 
PCV [1] Procarbazine 100 mg/m2 days 1 to 10 Every 6 to 8 weeks
Lomustine 100 mg/m2 day 1
Vincristine 1.5 mg/m2 (maximum 2 mg) day 1
PCV [2, 3] Procarbazine 60 mg/m2 days 8 to 21 Every 6 to 8 weeks
Lomustine 100 mg/m2 day 1
Vincristine 1.5 mg/m2 (maximum 2 mg) days 8 and 29
Temozolomide (standard)  150 to 200 mg/m2 daily for five days Every 4 weeks
Temozolomide (dose intensified)  150 mg/m2 daily days 1 to 7, 15 to 21 Every 4 weeks
75 to 100 mg/m2 daily days 1 to 21  Every 4 weeks
50 mg/m2 daily continuous   
Adjuvant temozolomide [4] 75 mg/m2 daily during RT  
Up to six cycles of 150 to 200 mg/m2 daily for 5 days, every 28 days
1. Medical Research Council trial. J Clin Oncol 2001; 19:509.
2. Levin, VA, et al. Int J Radiat Oncol Biol Phys 1990; 18:321.
3. van den Bent, MJ, et al. Neurology 1998; 51:1140.
4. Stupp, R, et al. N Engl J Med 2005; 352:987.
Graphic 57806 Version 2.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟